Skip to main content
SpringerLink
Log in

Mental Health in Cystic Fibrosis

  • Chapter
  • First Online:
Cystic Fibrosis

Part of the book series: Respiratory Medicine ((RM))

Abstract

Mental and physical health go hand in hand. Mental health challenges including depression and anxiety impact patients with cystic fibrosis (CF) and, ultimately, their health outcomes. This chapter provides an overview of various mental and psychosocial difficulties facing the CF community and recommendations for effective prevention, screening, and treatment of mental health concerns. The majority of research to date has focused on the consequences of anxiety and depression on CF adherence, health outcomes, quality of life, and family functioning. This chapter includes a brief discussion of other mental health considerations such as suicidality, disruptive behavior problems, and eating disorders and their treatments to provide a broader view of mental health in CF. Recommendations provided by the International Committee on Mental Health in Cystic Fibrosis (ICMH) for mental health screening and procedural follow-up as well as psychological and pharmacological treatments for disorders in the CF community are included.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Wells KB, Golding JM, Burnam MA. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatry. 1989;146:1440–6.

    CAS  PubMed  Google Scholar 

  2. Herrmann C. International experiences with the hospital anxiety and depression scale: a review of validation data and clinical results. J Psychosom Res. 1997;42:17–41.

    CAS  Google Scholar 

  3. Riolo SA, Nguyen TA, Greden JF, King CA. Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III. Am J Public Health. 2005;95:998–1000.

    PubMed  PubMed Central  Google Scholar 

  4. Roy-Byrne PP, Davidson KW, Kessler RC, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30:208–25.

    PubMed  Google Scholar 

  5. Whittemore R, Kanner S, Singleton S, Hamrin V, Chiu J, Grey M. Correlates of depressive symptoms in adolescents with type 1 diabetes. Pediatr Diabetes. 2002;3:135–43.

    PubMed  Google Scholar 

  6. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–7.

    CAS  PubMed  Google Scholar 

  7. Gorman JM. Comorbid depression and anxiety spectrum disorders. Depress Anxiety. 1996-1997;4:160–8.

    PubMed  Google Scholar 

  8. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res. 2002;53:859–63.

    PubMed  Google Scholar 

  9. Sherbourne CD, Wells KB, Meredith LS, Jackson CA, Camp P. Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry. 1996;53:889–95.

    CAS  PubMed  Google Scholar 

  10. Dowson CA, Kuijer RG, Mulder RT. Anxiety and self-management behavior in chronic obstructive pulmonary disease: what has been learned? Chron Respir Dis. 2004;1:213–20.

    CAS  PubMed  Google Scholar 

  11. Busse WW, Kiecolt-Glaser JK, Coe C, Martin RJ, Weiss ST, Parker SR. NHLBI workshop summary: stress and asthma. Am J Respir Crit Care Med. 1995;151:249–52.

    CAS  PubMed  Google Scholar 

  12. Patterson JM, Budd J, Goetz D, Warwick WJ. Family correlates of a 10-year pulmonary health trend in cystic fibrosis. Pediatrics. 1993;91:383–9.

    CAS  PubMed  Google Scholar 

  13. Wallander JL, Varni JW. Adjustment in children with chronic physical disorders: programmatic research on a disability stress-coping model. In: LaGreca AM, Siegal L, Wallander JL, Walker CE, editors. Stress and coping in child health. New York: Guilford Press; 1992. p. 279–98.

    Google Scholar 

  14. Quittner AL, DiGirolamo AM, Michel M, Eigen H. Parental response to cystic fibrosis: a contextual analysis of the diagnosis phase. J Pediatr Psychol. 1992;17:683–704.

    CAS  PubMed  Google Scholar 

  15. Quittner AL, DiGirolamo AM. Family adaptation to childhood disability and illness. In: Ammerman RT, Campo JV, editors. Handbook of pediatric psychology and psychiatry. Boston: Allyn & Bacon; 1998. p. 70–102.

    Google Scholar 

  16. Quittner AL, Goldbeck L, Abbott J, et al. Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries. Thorax. 2014;69(12):1090–7.

    PubMed  Google Scholar 

  17. Quittner AL, Abbott J, Georgiopoulos AM, Goldbeck L, Smith B, Hempstead SE, Marshall B, Sabadosa KA, Elborn S. International committee on mental health. International committee on mental health in cystic fibrosis: cystic fibrosis foundation and european cystic fibrosis society consensus statements for screening and treating depression and anxiety. Thorax. 2016;71:26–34.

    PubMed  Google Scholar 

  18. Abbott J, Havermans T, Jarvholm S, Landau E, Prins Y, Smrekar U, Staab D, Verity L, Verkleij M. ECFS Mental Health Working Group. Mental health screening in cystic fibrosis centres across Europe. J Cyst Fibros. 2019;18(2):299–303. https://doi.org/10.1016/j.jcf.2018.09.003.

    Article  CAS  PubMed  Google Scholar 

  19. Duff AJ. Depression in cystic fibrosis; implications of The International Depression/Anxiety Epidemiological Study (TIDES) in cystic fibrosis. Paediatr Respir Rev. 2015;16:2–5. https://doi.org/10.1016/j.prrv.2015.07.006.

    Article  PubMed  Google Scholar 

  20. American Psychiatric Association, editor. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed: American Psychiatric Publishing, Incorporated; 2013.

    Google Scholar 

  21. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Kessler RC, Avenevoli S, Costello EJ, et al. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry. 2012;69(4):372–80. https://doi.org/10.1001/archgenpsychiatry.2011.160.

    Article  PubMed  Google Scholar 

  23. Smith BA, Modi AC, Quittner AL, et al. Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatr Pulmonol. 2010;45:756–63.

    PubMed  Google Scholar 

  24. Havermans T, Colpaert K, Dupont LJ. Quality of life in patients with cystic fibrosis: association with anxiety and depression. J Cyst Fibros. 2008;7:581–4.

    PubMed  Google Scholar 

  25. Riekert KA, Bartlett SJ, Boyle MP, et al. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest. 2007;132:231–7.

    PubMed  Google Scholar 

  26. Latchford G, Duff AJ. Screening for depression in a single CF centre. J Cyst Fibros. 2013;12:794–6.

    PubMed  Google Scholar 

  27. Besier T, Born A, Henrich G, et al. Anxiety, depression, and life satisfaction in parents caring for children with cystic fibrosis. Pediatr Pulmonol. 2011;46:672–82.

    PubMed  Google Scholar 

  28. Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin N Am. 2009;32:483–524. https://doi.org/10.1016/j.psc.2009.06.002.

    Article  Google Scholar 

  29. Kessler RC, Avenevoli S, Ries Merikangas K. Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry. 2001;49(12):1002–14.

    CAS  PubMed  Google Scholar 

  30. Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980–9. PMID: 20855043

    PubMed  PubMed Central  Google Scholar 

  31. MacLean J, Kinley DJ, Jacobi F, Bolton JM, Sareen J. The relationship between physical conditions and suicidal behavior among those with mood disorders. J Affect Disord. 2011;130:245–50.

    PubMed  Google Scholar 

  32. Weissman MM, Wolk S, Goldstein RB, et al. Depressed adolescents grown up. JAMA. 1999;281(18):1707–13. https://doi.org/10.1001/jama.281.18.1707.

    Article  CAS  PubMed  Google Scholar 

  33. Druss B, Pincus H. Suicidal ideation and suicide attempts in general medical illnesses. Arch Intern Med. 2000;160(10):1522–6.

    CAS  PubMed  Google Scholar 

  34. Garcia G, Snell C, Sawicki G, et al. Mental health screening of medically admitted patients with cystic fibrosis. Psychosomatics. 2018;59(2):158–68.

    PubMed  Google Scholar 

  35. Quon BS, Bentham WD, Unutzer J, Chan YF, Goss CH, Aitken ML. Prevalence of symptoms of depression and anxiety in adults with cystic fibrosis based on the PHQ-9 and GAD-7 screening questionnaires. Psychosomatics. 2015;56(4):345–53.

    PubMed  Google Scholar 

  36. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.

    PubMed  Google Scholar 

  37. Bennett, S., & Walkup, J. (2016). Anxiety disorders in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, and course. Retrieved from http://www.uptodate.com/contents/anxiety-disorders-inchildren-and-adolescents-epidemiologypathogenesis-clinical-manifestationsand-course?source=search_result&search=Anxiety+disorders+in+children+and+adolescents%3A+Epidemiology%2C+pathogenesis%2C+clinical+manifestations%2C+and+course&selectedTitle=1~150

  38. Harvard Medical School, 2007. National Comorbidity Survey (NCS). (2017, August 21). Retrieved from https://www.hcp.med.harvard.edu/ncs/index.php. Data table 1: lifetime prevalence DSM-IV/WMH-CIDI disorders by sex and cohort.

  39. Yohannes AM, Willgoss TG, Fatoye FA, et al. Relationship between anxiety, depression, and quality of life in adult patients with cystic fibrosis. Respir Care. 2012;57:550–6.

    PubMed  Google Scholar 

  40. Georgiopoulos AM, Friedman D, Porter EA, Krasner A, Kakarala SP, Glaeser BK, et al. Screening for ADHD in adults with cystic fibrosis: prevalence, health-related quality of life, and adherence. J Cyst Fibros. 2018;17(2):276–80.

    PubMed  Google Scholar 

  41. Cohen-Cymberknoh M, Tanny T, Breuer O, Blau H, Mussaffi H, Kadosh D, et al. Attention deficit hyperactivity disorder symptoms in patients with cystic fibrosis. J Cyst Fibros. 2018;17(2):281–5.

    PubMed  Google Scholar 

  42. Georgiopoulos AM, Hua LL. The diagnosis and treatment of attention deficit-hyperactivity disorder in children and adolescents with cystic fibrosis: a retrospective study. Psychosomatics. 2011;52:160–6.

    PubMed  Google Scholar 

  43. Beker LT, Russek-Cohen E, Fink RJ. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc. 2001;101(4):438–42.

    CAS  PubMed  Google Scholar 

  44. Konstan M, Butler S, Wohl M, Stoddard M, Matousek R, Wagener J, et al. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr. 2003;142(6):624–30.

    PubMed  Google Scholar 

  45. Peterson ML, Jacobs DR, Milla CE. Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics. 2003;112(3):588–92.

    PubMed  Google Scholar 

  46. Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008;108:832e9.

    Google Scholar 

  47. Crist W, McDonnell P, Beck M, Gillespie C, Barrett P, Mathews J. Behavior at mealtimes and the young child with cystic fibrosis. J Dev Behav Pediatr. 1994;15:157–61.

    Google Scholar 

  48. Stark L, Jelalian E, Opipari L, Powers S, Janicke D, Mulvihill M, et al. Child behavior and parent management strategies at mealtimes in families with a school-age child with cystic fibrosis. Health Psychol. 2005;24:274–80.

    PubMed  Google Scholar 

  49. Ward C, Massie J, Glazner J, et al. Problem behaviours and parenting in preschool children with cystic fibrosis. Arch Dis Child. 2009;94:341–7.

    CAS  PubMed  Google Scholar 

  50. Tierney S. Body image and cystic fibrosis: a critical review. Body Image. 2012;9(1):12–9.

    PubMed  Google Scholar 

  51. Swanson SA, Crow SJ, Le Grange D, Swendsen J, Merikangas KR. Prevalence and correlates of eating disorders in adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry. 2011;68(7):714–23. https://doi.org/10.1001/archgenpsychiatry.2011.22.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Udo T, Grilo CM. Prevalence and correlates of DSM-5–defined eating disorders in a nationally representative sample of U.S. adults. Biol Psychiatry. 2018;84:345–54.

    PubMed  PubMed Central  Google Scholar 

  53. Raymond N, Chang P, Crow S, Mitchell J, Bieperink B, Beck M, Crosby RD, Clawson CC, Warwick WJ. Eating disorders in patients with cystic fibrosis. J Adolesc. 2000;23:359–63.

    CAS  PubMed  Google Scholar 

  54. Bryon M, Shearer J, Davies H. Eating disorders and disturbance in children and adolescents with cystic fibrosis. Child Health Care. 2008;36:67–77.

    Google Scholar 

  55. Shearer J, Bryon M. The nature and prevalence of eating disorders and eating disturbance in adolescents with cystic fibrosis. J R Soc Med. 2004;97:36–42.

    PubMed  PubMed Central  Google Scholar 

  56. Bartlett SJ, Krishnan JA, Riekert KA, et al. Maternal depressive symptoms and adherence to therapy in inner-city children with asthma. Pediatrics. 2004;113:229–37.

    PubMed  Google Scholar 

  57. Stewart SM, Rao U, White P. Depression and diabetes in children and adolescents. Curr Opin Pediatr. 2005;17:626–31.

    PubMed  Google Scholar 

  58. White T, Miller J, Smith GL, McMahon WM. Adherence and psychopathology in children and adolescents with cystic fibrosis. Eur Child Adolesc Psychiatry. 2009;18:96–104.

    PubMed  Google Scholar 

  59. Linkson L, Macedo P, Perrin FM, et al. Anorexia nervosa in cystic fibrosis. Paediatr Respir Rev. 2018;26:24–6.

    PubMed  Google Scholar 

  60. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007;29:147–55.

    PubMed  Google Scholar 

  61. James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2005;4:CD004690.

    Google Scholar 

  62. Fidika A, Herle M, Goldbeck L. Symptoms of depression impact the course of lung function in adolescents and adults with cystic fibrosis. BMC Pulm Med. 2014;14:205.

    PubMed  PubMed Central  Google Scholar 

  63. Snell C, Fernandes S, Bujoreanu IS, Garcia G. Depression, illness severity, and healthcare utilization in cystic fibrosis. Pediatr Pulmonol. 2014;49(12):1177–81.

    PubMed  Google Scholar 

  64. Schechter MS, Ostrenga JS, Fink AK, Barker DH, Sawicki GS, Quittner AL. Decreased survival in cystic fibrosis patients with a positive screen for depression. Thorax 2019; submitted for publication.

    Google Scholar 

  65. Bregnballe V, Thastum M, Schiøtz PO. Psychosocial problems in children with cystic fibrosis. Acta Paediatr. 2007;96:58–61.

    CAS  PubMed  Google Scholar 

  66. Anderson DL, Flume PA, Hardy KK. Psychological functioning of adults with cystic fibrosis. Chest. 2001;119:1079–84.

    CAS  PubMed  Google Scholar 

  67. Quittner AL, Buu A, Messer MA, Modi AC, Watrous M. Development and validation of the cystic fibrosis questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest. 2005;128:2347–54.

    PubMed  Google Scholar 

  68. Cronly JA, Duff AJ, Riekert KA, Fitzgerald AP, Perry IJ, Lehane EA, Horgan A, Howe BA, Chroinin MN, Savage E. Health-related quality of life in adolescents and adults with cystic fibrosis: physical and mental health predictors. Respir Care. 2019;64(4):406–41.

    PubMed  Google Scholar 

  69. Knudsen K, Pressler T, Mortensen L, et al. Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis. Springer Plus. 2016;5:1216.

    CAS  PubMed  Google Scholar 

  70. Szyndler JE, Towns SJ, van Asperen PP, McKay KO. Psychological and family functioning and quality of life in adolescents with cystic fibrosis. J Cyst Fibros. 2005;4:135–44.

    PubMed  Google Scholar 

  71. Spieth LE, Stark LJ, Mitchell MJ, et al. Observational assessment of family functioning at mealtime in preschool children with cystic fibrosis. J Pediatr Psychol. 2001;26:215–24.

    CAS  PubMed  Google Scholar 

  72. McClellan CB, Cohen LL. Family functioning in children with chronic illness compared with healthy controls: a critical review. J Pediatr. 2007;150:221–3.

    PubMed  Google Scholar 

  73. Everhart RS, Fiese BH, Smyth JM, Borschuk A, Anbar RD. Family functioning and treatment adherence in children and adolescents with cystic fibrosis. Pediatr Allergy Immunol Pulmonol. 2014;27(2):82–6.

    PubMed  PubMed Central  Google Scholar 

  74. van Zoonen K, Buntrock C, Ebert DD, et al. Preventing the onset of major depressive disorder: a meta-analytic review of psychological interventions. Int J Epidemiol. 2014;43(2):318–29.

    PubMed  PubMed Central  Google Scholar 

  75. Uman LS, Birnie KA, Noel M, et al. Psychological interventions for needle-related procedural pain and distress in children and adolescents. Cochrane Database Syst Rev. 2013;10:CD005179.

    Google Scholar 

  76. Stark LJ, Quittner AL, Powers SW, et al. Randomized clinical trial of behavioral intervention and nutrition education to improve caloric intake and weight in children with cystic fibrosis. Arch Pediatr Adolesc Med. 2009;163(10):915–21.

    PubMed  PubMed Central  Google Scholar 

  77. Archer J, Bower P, Gilbody S, et al. Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev. 2012;10:CD006525.

    PubMed  Google Scholar 

  78. Walker J, Hansen CH, Martin P, et al. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer. Lancet Oncol. 2014;15(10):1168–76.

    PubMed  Google Scholar 

  79. Huffman JC, Mastromauro CA, Beach SR, et al. Collaborative care for depression and anxiety disorders in patients with recent cardiac events: the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. JAMA Intern Med. 2014;174(6):927–35.

    CAS  PubMed  Google Scholar 

  80. Rachman S. The evolution of cognitive behaviour therapy. In: Clark DF, Fairburn CG, Gelder MG, editors. Science and practice of cognitive behaviour therapy. Oxford, UK: Oxford University Press; 1997. p. 1–26.

    Google Scholar 

  81. Markowitz JC, Lipsitz J, Milrod BL. Critical review of outcome research on interpersonal psychotherapy for anxiety disorders. Depress Anxiety. 2014;31:316–25.

    PubMed  PubMed Central  Google Scholar 

  82. Swartz HA, Grote NK, Graham P. Brief interpersonal psychotherapy (IPT-B): overview and review of evidence. Am J Psychother. 2014;68:443–62.

    PubMed  PubMed Central  Google Scholar 

  83. Kass AE, Kolko RP, Wilfley DE. Psychological treatments for eating disorders. Curr Opin Psychiatry. 2013;26:549–55.

    PubMed  PubMed Central  Google Scholar 

  84. Casier A, Goubert L, Huse D, et al. The role of acceptance in psychological functioning in adolescents with cystic fibrosis: a preliminary study. Psychol Health. 2008;23:629–38.

    CAS  PubMed  Google Scholar 

  85. Wicksell RK, Kanstrup M, Kemani MK, Holmström L, Olsson GL. Acceptance and commitment therapy for children and adolescents with physical health concerns. Curr Opin Psychol. 2015;2:1–5.

    Google Scholar 

  86. Bennett DS, O’Hayer CV, Wolfe W, Juarascio A, Winch E. Reducing anxiety & depression among individuals with cystic fibrosis through acceptance and commitment therapy: a treatment manual including adaptation for telehealth. Department of Psychiatry: Drexel University.

    Google Scholar 

  87. Dimeff LA, Koerner K, editors. Dialectical behavior therapy in clinical practice: applications across disorders and settings. New York: Guilford Press; 2007.

    Google Scholar 

  88. Telch CF, Agras WS, Linehan MM. Dialectical behavior therapy for binge eating disorder. J Consult Clin Psychol. 2001;69(6):1061–5.

    CAS  PubMed  Google Scholar 

  89. Stark LJ, Powers SW, Jelalian E, Rape RN, Miller DL. Modifying problematic mealtime interactions of children with cystic fibrosis and their parents via behavioral parent training. J Pediatr Psychol. 1994;19(6):751–68.

    CAS  PubMed  Google Scholar 

  90. Powers SW, Stark LJ, Chamberlin LA, et al. Behavioral and nutritional treatment for preschool-aged children with cystic fibrosis: a randomized clinical trial. JAMA Pediatr. Published online May 01, 2015;169(5):e150636. https://doi.org/10.1001/jamapediatrics.2015.0636.

  91. Chronis AM, Chacko A, Fabiano GA, et al. Enhancements to the behavioral parent training paradigm for families of children with ADHD: review and future directions. Clin Child Fam Psychol Rev. 2004;7:1. https://doi.org/10.1023/B:CCFP.0000020190.60808.a4.

    Article  PubMed  Google Scholar 

  92. Smith BA, Georgiopoulos AM, Quittner AL. Maintaining mental health and function for the long run in cystic fibrosis. Pediatr Pulmonol. 2016;51(S44):S71–8. https://doi.org/10.1002/ppul.23522.

    Article  PubMed  Google Scholar 

  93. Milano W, De Rosa M, Milano L, Riccio A, Sanseverino B, Capasso A. The pharmacological options in the treatment of eating disorders. ISRN Pharmacol. 2013;352865 https://doi.org/10.1155/2013/352865.

  94. American Academy of Pediatrics, Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–22.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Virginia Commonwealth University, Department of Psychology, Richmond, VA, USA

    Kathryn L. Behrhorst & Robin S. Everhart

  2. Division of Pulmonary Medicine, Department of Pediatrics, Virginia Commonwealth University, Children’s Hospital of Richmond at VCU, Richmond, VA, USA

    Michael S. Schechter

Authors
  1. Kathryn L. Behrhorst
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robin S. Everhart
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael S. Schechter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kathryn L. Behrhorst .

Editor information

Editors and Affiliations

  1. The University of North Carolina at Chapel Hill, Department of Pediatrics, UNC Children’s Hospital, Chapel Hill, NC, USA

    Stephanie Duggins Davis

  2. Department of Pediatrics, University of Washington School of Medicine, Division of Pulmonary and Sleep Medicine, Seattle Children’s Hospital, Seattle, WA, USA

    Margaret Rosenfeld

  3. Department of Pediatrics, Indiana University School of Medicine, Division of Pediatric Pulmonology, Allergy and Sleep Medicine, Riley Hospital for Children at IU Health, Indianapolis, IN, USA

    James Chmiel

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Behrhorst, K.L., Everhart, R.S., Schechter, M.S. (2020). Mental Health in Cystic Fibrosis. In: Davis, S., Rosenfeld, M., Chmiel, J. (eds) Cystic Fibrosis. Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-030-42382-7_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-42382-7_21

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-42381-0

  • Online ISBN: 978-3-030-42382-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation